EE9700068A - Selegiliini kasutamine epileptiliste haiguste raviks - Google Patents

Selegiliini kasutamine epileptiliste haiguste raviks

Info

Publication number
EE9700068A
EE9700068A EE9700068A EE9700068A EE9700068A EE 9700068 A EE9700068 A EE 9700068A EE 9700068 A EE9700068 A EE 9700068A EE 9700068 A EE9700068 A EE 9700068A EE 9700068 A EE9700068 A EE 9700068A
Authority
EE
Estonia
Prior art keywords
pct
selegiline
treatment
date feb
epileptic diseases
Prior art date
Application number
EE9700068A
Other languages
English (en)
Other versions
EE04176B1 (et
Inventor
L�scher Wolfgang
Original Assignee
Arzneimittelwerk Dresden Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arzneimittelwerk Dresden Gmbh filed Critical Arzneimittelwerk Dresden Gmbh
Publication of EE9700068A publication Critical patent/EE9700068A/et
Publication of EE04176B1 publication Critical patent/EE04176B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EE9700068A 1994-08-11 1995-07-27 Selegiliini kasutamine epileptiliste haiguste raviks mõeldud ravimpreparaatide valmistamiseks EE04176B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4428444A DE4428444A1 (de) 1994-08-11 1994-08-11 Verwendung von Selegilin zur Behandlung von epileptischen Erkrankungen
PCT/DE1995/000981 WO1996004897A1 (de) 1994-08-11 1995-07-27 Verwendung von selegilin zur behandlung von epileptischen erkrankungen

Publications (2)

Publication Number Publication Date
EE9700068A true EE9700068A (et) 1997-10-15
EE04176B1 EE04176B1 (et) 2003-12-15

Family

ID=6525440

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9700068A EE04176B1 (et) 1994-08-11 1995-07-27 Selegiliini kasutamine epileptiliste haiguste raviks mõeldud ravimpreparaatide valmistamiseks

Country Status (23)

Country Link
US (1) US5952388A (et)
EP (1) EP0774961B1 (et)
JP (1) JP3922307B2 (et)
CN (1) CN1081918C (et)
AT (1) ATE239458T1 (et)
AU (1) AU691316B2 (et)
BR (1) BR9508531A (et)
CA (1) CA2197176C (et)
CZ (1) CZ285681B6 (et)
DE (2) DE4428444A1 (et)
DK (1) DK0774961T3 (et)
EE (1) EE04176B1 (et)
ES (1) ES2199252T3 (et)
HU (1) HU223529B1 (et)
MY (1) MY116362A (et)
NO (1) NO314684B1 (et)
PL (1) PL188040B1 (et)
PT (1) PT774961E (et)
RU (1) RU2155584C2 (et)
SK (1) SK283205B6 (et)
TR (1) TR199500984A2 (et)
TW (1) TW448044B (et)
WO (1) WO1996004897A1 (et)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19630035A1 (de) * 1996-07-25 1998-01-29 Asta Medica Ag Tramadol Multiple Unit Formulierungen
DE19716905C1 (de) * 1997-04-22 1998-08-27 Iip Inst Fuer Ind Pharmazie Fo Stabile, wäßrige Lösung auf der Grundlage von Selegilin und Vorrichtung zu ihrer Verabreichung
DE19743323C2 (de) * 1997-09-30 2000-05-25 Iip Inst Fuer Ind Pharmazie Fo Feste Arzneimittelzusammensetzung auf der Grundlage von Selegilin
ATE427745T1 (de) * 2001-11-05 2009-04-15 Krele Pharmaceuticals Llc Zusammensetzungen und verfahren zur erhíhung der compliance mit therapien unter verwendung von aldehyddehydrogenase-hemmern und zur behandlung von alkoholsmus
GB201715919D0 (en) * 2017-09-29 2017-11-15 Gw Res Ltd use of cannabinoids in the treatment of epilepsy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192808A (en) * 1990-08-31 1993-03-09 Deprenyl Animal Health, Inc. Therapeutic effect of L-deprenyl in the management of pituitary-dependent hyperadrenocorticism (cushing's disease)
WO1992017169A1 (en) * 1991-04-04 1992-10-15 The University Of Toronto Innovations Foundation Use of deprenyl to maintain, prevent loss, or recover nerve cell function
US5648087A (en) * 1993-03-09 1997-07-15 Sanofi Sante Nutrition Animale Anaesthetic pharmaceutical composition comprising a general anaesthetic and selegiline
US5462740A (en) * 1993-09-17 1995-10-31 Athena Neurosciences, Inc. Rectally-administered, epileptic-seizure-inhibiting composition

Also Published As

Publication number Publication date
CA2197176C (en) 2007-06-26
PL188040B1 (pl) 2004-11-30
WO1996004897A1 (de) 1996-02-22
US5952388A (en) 1999-09-14
NO314684B1 (no) 2003-05-05
ATE239458T1 (de) 2003-05-15
TW448044B (en) 2001-08-01
TR199500984A2 (tr) 1996-06-21
DE4428444A1 (de) 1996-02-15
PT774961E (pt) 2003-09-30
HUT77175A (hu) 1998-03-02
AU2976095A (en) 1996-03-07
DK0774961T3 (da) 2003-09-01
SK283205B6 (sk) 2003-03-04
PL318292A1 (en) 1997-06-09
MX9701031A (es) 1998-05-31
CZ40797A3 (en) 1997-07-16
CN1155241A (zh) 1997-07-23
HU223529B1 (hu) 2004-08-30
DE59510674D1 (de) 2003-06-12
NO970607L (no) 1997-02-10
NO970607D0 (no) 1997-02-10
JP3922307B2 (ja) 2007-05-30
ES2199252T3 (es) 2004-02-16
BR9508531A (pt) 1998-12-01
SK19997A3 (en) 1997-08-06
MY116362A (en) 2004-01-31
RU2155584C2 (ru) 2000-09-10
AU691316B2 (en) 1998-05-14
EP0774961A1 (de) 1997-05-28
CA2197176A1 (en) 1996-02-22
JPH10504029A (ja) 1998-04-14
EE04176B1 (et) 2003-12-15
CN1081918C (zh) 2002-04-03
CZ285681B6 (cs) 1999-10-13
EP0774961B1 (de) 2003-05-07

Similar Documents

Publication Publication Date Title
PT777483E (pt) Metodos e meio para administrar farmacos
DE60126980D1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
NO963239D0 (no) Klorpyrimid-mellomprodukter
ES2166111T3 (es) Uso de tiagabina para el tratamiento de trastornos del sueño.
BG106095A (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
BR9707366A (pt) Novos aminoácidos ciclicos como agentes farmacéuticos
BR0108977A (pt) Compostos azacìclicos para uso no tratamento de doenças relaciondas com serotonina
ATE279919T1 (de) Agmatin für die behandlung neuropathischer schmerzen
DE60038252D1 (de) Menschlicher antikörper gegen gangliosid gd3 für die transplantationskomplementarität bestimmente regionund derivate des antikörpers gegen das gangliosid gd3
ES2163034T3 (es) Composiciones micelares de copolimeros de bloque de polieter, para la objetivizacion de agentes biologicos como diana.
DE69400799D1 (de) Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen
DE60312736D1 (de) 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems
EE9700068A (et) Selegiliini kasutamine epileptiliste haiguste raviks
PT983300E (pt) Sais peptidicos de bpc com actividade organo-protectora, processo para a sua preparacao e sua utilizacao em terapia
NO20005548L (no) Mykobakterieinhibitorer
DE69627298D1 (de) Verwendung von sklareolide für die behandlung von excessiven zellwachstumskrankheiten
ES2140544T3 (es) Utilizacion de efaroxan y de sus derivados para la fabricacion de medicamentos destinados al tratamiento de las enfermedades neurodegenerativas.
BR0206918A (pt) Uso de iloperidona
DK1007047T3 (da) Anvendelse af mizolastin til fremstilling af et lægemiddel beregnet til inflammationsbehandling
ES2181160T3 (es) Derivados de 1,4-dihidropiridina y su utilizacion en terapia.

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

HE1A Change of address
KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

MM4A Lapsed by not paying the annual fees

Effective date: 20080727